2m 2m 2m 2m 2m 2m 2m
Alpha Tau Med (DRTS)
NASDAQ
$9.95-$0.08 (-0.85%)
Price as of Jun 23, 2026 5:57 PM EDT- $334.4MMarket Cap
- 236.01%1-Year Change
- BiotechnologyIndustry
Alpha Tau Med (DRTS)
$9.95-$0.08 (-0.85%)
DRTS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.03 | ||
Change | +$0.25 (+2.56%) | ||
Open | $9.69 | ||
High | $10.19 | ||
Low | $9.62 | ||
Previous Close | $9.78 | ||
Volume | 567,927 | ||
30-Day Average Volume | 983,583 | ||
1-Week Change | 3.72% | ||
1-Month Change | -0.10% | ||
1-Year Change | 236.01% | ||
3-Year Change | 137.68% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 33.3M | ||
Total Assets | $105.7M | ||
Market Cap | $334.4M | ||
Enterprise Value | $328.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue